Accelerate to discover

Back to filter

Related topics

EV's and Nanoparticles in "Full Spectrum View" with the new Cytek ESP module

Cytek Biosciences

Jul 19, 2024

Cytek’s Enhanced Small Particle (ESP) Detection Option expands the capability of your Cytek Aurora or Cytek Northern...

Automatic, Real Time Acquisition of Bioluminescent Kinetic Curves

Spectral Instruments Imaging

Jun 27, 2024

Watch this pre-recorded webinar with Dr. Andrew Van Praagh to learn how our new Aura software feature —Kinetics—...

Orion 2024 AACR poster: 17-plex single-step stain and imaging of cell Lung Carcinoma

RareCyte

Jun 21, 2024

RareCyte Orion is a benchtop, high resolution, whole slide multimodal imaging instrument. A combination of quantitative...

New release now available: Cytek Amnis AI v3.0 Software

Cytek Biosciences

Jun 17, 2024

The new Cytek Amnis AI v3.0 image analysis software features an integrated transfer learning algorithm, an option to...

Jul 22, 2024

Cytek webinar: Imaging Flow Cytometry for Chromosomal Assessment in Hematological Malignancies

Cytek Biosciences

Jun 7, 2024

In this webinar, we will describe a new innovative approach we developed that resolves these limitations. The method...

Hypoxia in the Tumor Immune Microenvironment (TIME)

Bruker Biospin

Jun 6, 2024

Thursday, 11 July 2024, 16:00 CET | 10:00 EST
Zaver M. Bhujwalla, PhD...

Exosome-Mediated Delivery of Small Molecules, RNA & DNA for Development of Novel Cancer Therapeutics

Spectral Instruments Imaging

Jun 3, 2024

Disha Moholkar of University of Louisville's Gupta Lab
Tuesday, June 11, 2024, 6:30 PM
...

Jul 22, 2024

Emulate in vivo conditions – introduce shear flow to your experiments with BioFlux system

Cell Microsystems

May 27, 2024

Most research is still conducted in vitro without the presence of flow. We use the BioFlux System to give you the...

Show all topics (10)

The evaluation of three digital PCR platforms for residual disease in chronic myeloid leukemia

Oct 11, 2016

Thursday, October 13, 2016, 5 pm CEST

Mary Alikian, Ph.D., Imperial Molecular Pathology laboratory and the Department of Haematology at Hammersmith Hospital, Imperial College London

The BCR-ABL1 fusion gene sequence is used to help diagnose and monitor treatment and recurrence for chronic myelogenous leukemia (CML). In fact, between 90-95% of diagnosed CML cases are BCR-ABL1-positive. While reverse transcription quantitative PCR (RT-qPCR) is the gold standard strategy for monitoring BCR-ABL1 transcripts, there can often be challenges with reproducibility due to the technology and workflow. Reverse-Transcription Digital PCR (RT-dPCR) is an adaptation of this method that could provide the robust and standardized workflow needed for patient stratification. In this webinar, Dr. Mary Alikian at Hammersmith Hospital, Imperial College London, discussed her team’s comparison of three different available dPCR platforms (ThermoFisher Scientific’s QuantStudio 3D System, Bio-Rad’s QX200 System and RainDance’s RainDrop System) and investigation of whether they could be applied to a clinical research setting to quantify BCR-ABL1 transcripts in CML patients. The team determined that only the RainDrop System was able to detect and quantitatively measure BCR-ABL1 transcripts in the <0.001% range at a level higher than the false positive rate in the control patient groups.

Register now

Technical breakthrough
Webinar

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

RainDance Technologies

RainDance company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases.

Related products

Capable of generating more than a billion reactions in a single day, the RainDrop system surpasses all existing technologies and establishes a new performance standard in sensitivity, quantitation and multiplexing.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey